Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I-III Clinical Trials.
Ahmed A SuleimanMukul MinochaAmit KhatriYinuo PangAhmed A OthmanPublished in: Clinical pharmacokinetics (2020)
NCT01577550, NCT02054481, NCT02596217, NCT02684370, NCT02672852, NCT02684357, NCT02694523.